Aethlon Medical stockholders elect five directors, approve 2020 Plan increase at October 1 meeting
At its virtual annual meeting on October 1, 2026, Aethlon Medical's stockholders elected five directors, approved an increase of 100,000 shares to the 2020 Equity Incentive Plan, and approved a series of other proposals. The filing also shows stockholders approved raising authorized common stock from 20,000,000 to 200,000,000 shares, which could allow future share issuance and dilution for holders of the current 711,136 outstanding shares.
Key points
- Five directors elected, including Chetan S. Shah, MD and Nicolas Gikakis, each for terms ending at the next annual meeting
- Stockholders approved a 100,000-share increase to the 2020 Equity Incentive Plan, effective October 1, 2026
- Proposal to increase authorized common shares from 20,000,000 to 200,000,000 passed with 370,879 votes for and 27,208 against
- Approximately 56.21% of the 711,136 eligible shares were represented, establishing a quorum
The filing
Written by AI on Nov 9, 2026, 8:29 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 01, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.